Gaglia J - Search Results

1

Anti-CD3 Antibody for the Prevention of Type 1 Diabetes: A Story of Perseverance.

Gaglia J, Kissler S. Gaglia J, et al. Biochemistry. 2019 Oct 8;58(40):4107-4111. doi: 10.1021/acs.biochem.9b00707. Epub 2019 Sep 24. Biochemistry. 2019. PMID: 31523950 Free PMC article. Review.

2

Adult-onset autoimmune diabetes.

Buzzetti R, Maddaloni E, Gaglia J, Leslie RD, Wong FS, Boehm BO. Buzzetti R, et al. Among authors: gaglia j. Nat Rev Dis Primers. 2022 Sep 22;8(1):63. doi: 10.1038/s41572-022-00390-6. Nat Rev Dis Primers. 2022. PMID: 36138034 Review.

3

Islet transplantation: progress and challenge.

Gaglia JL, Shapiro AM, Weir GC. Gaglia JL, et al. Arch Med Res. 2005 May-Jun;36(3):273-80. doi: 10.1016/j.arcmed.2005.03.014. Arch Med Res. 2005. PMID: 15925017 Review.

4

Inadequate β-cell mass is essential for the pathogenesis of type 2 diabetes.

Weir GC, Gaglia J, Bonner-Weir S. Weir GC, et al. Among authors: gaglia j. Lancet Diabetes Endocrinol. 2020 Mar;8(3):249-256. doi: 10.1016/S2213-8587(20)30022-X. Epub 2020 Jan 29. Lancet Diabetes Endocrinol. 2020. PMID: 32006519 Free PMC article. Review.

5

β-cell secretory dysfunction: a key cause of type 2 diabetes - Authors' reply.

Weir GC, Gaglia J, Bonner-Weir S. Weir GC, et al. Among authors: gaglia j. Lancet Diabetes Endocrinol. 2020 May;8(5):370-371. doi: 10.1016/S2213-8587(20)30120-0. Lancet Diabetes Endocrinol. 2020. PMID: 32333872 No abstract available.

6

Exenatide extended release in patients with type 1 diabetes with and without residual insulin production.

Herold KC, Reynolds J, Dziura J, Baidal D, Gaglia J, Gitelman SE, Gottlieb PA, Marks J, Philipson LH, Pop-Busui R, Weinstock RS. Herold KC, et al. Among authors: gaglia j. Diabetes Obes Metab. 2020 Nov;22(11):2045-2054. doi: 10.1111/dom.14121. Epub 2020 Jul 29. Diabetes Obes Metab. 2020. PMID: 32573927 Free PMC article. Clinical Trial.

7

More on Semaglutide in Early Type 1 Diabetes.

Gaglia JL, Laffel LM, Patti ME. Gaglia JL, et al. N Engl J Med. 2024 Jan 18;390(3):291. doi: 10.1056/NEJMc2311608. N Engl J Med. 2024. PMID: 38231642 No abstract available.

8

Novel Autologous Dendritic Cell Therapy AVT001 for Type 1 Diabetes.

Gaglia JL, Daley HL, Bryant NK, Ritz J, Dong T, Skyler JS, Jiang H. Gaglia JL, et al. NEJM Evid. 2024 Jul;3(7):EVIDoa2300238. doi: 10.1056/EVIDoa2300238. Epub 2024 Jun 25. NEJM Evid. 2024. PMID: 38916421 Free PMC article. Clinical Trial.

9

Islet recovery and reversal of murine type 1 diabetes in the absence of any infused spleen cell contribution.

Nishio J, Gaglia JL, Turvey SE, Campbell C, Benoist C, Mathis D. Nishio J, et al. Among authors: gaglia jl. Science. 2006 Mar 24;311(5768):1775-8. doi: 10.1126/science.1124004. Science. 2006. PMID: 16556845

10

Noninvasive imaging of pancreatic islet inflammation in type 1A diabetes patients.

Gaglia JL, Guimaraes AR, Harisinghani M, Turvey SE, Jackson R, Benoist C, Mathis D, Weissleder R. Gaglia JL, et al. J Clin Invest. 2011 Jan;121(1):442-5. doi: 10.1172/JCI44339. Epub 2010 Dec 1. J Clin Invest. 2011. PMID: 21123946 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

58 results

Search Page

Filters